Gastrointestinal hormones and metabolic signals can influence central circuits such as reward, memory, and executive control, forming an important driving force for the development and maintenance of obesity, and the modulation of these signals by drugs such as GLP-1 provides new therapeutic ideas for the management of obesity. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.